Statins and autoimmunity: State-of-the-art-Reference-Cited by-同舟云学术

Statins and autoimmunity: State-of-the-art

Published:2020-10 Issue: Volume:214 Page:107614
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Dehnavi Sajad,Sohrabi Nasrollah,Sadeghi Mahvash,Lansberg Peter,Banach Maciej,Al-Rasadi Khalid,Johnston Thomas P.,Sahebkar Amirhossein

Funder

Amgen

Boehringer Ingelheim

Novo Nordisk

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference168 articles.

1. Statins as immunomodulators in systemic sclerosis;Abou-Raya;Annals of the New York Academy of Sciences,2007

2. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud’s phenomenon and digital ulcers;Abou-Raya;The Journal of Rheumatology,2008

3. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study;Abud-Mendoza;Lupus,2003

4. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update;Agca;Annals of the Rheumatic Diseases,2017

5. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study;Albert;Jama,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins in Graves Orbitopathy: A New Therapeutic Tool;Ophthalmic Plastic & Reconstructive Surgery;2023-12

2. Navigating the landscape of Rho GTPase signalling system in autoimmunity: A bibliometric analysis spanning over three decades (1990 to 2023);Cellular Signalling;2023-11

3. Drug-microbiota interactions: an emerging priority for precision medicine;Signal Transduction and Targeted Therapy;2023-10-09

4. Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics;Cardiovascular Research;2023-08-18

5. Association between the use of lipid‐lowering drugs and the risk of inflammatory bowel disease;European Journal of Clinical Investigation;2023-07-28